Unique indications,Count
Breast Cancer,104
Ovarian Cancer,31
Triple Negative Breast Cancer,29
Metastatic Breast Cancer,29
Non-small Cell Lung Cancer,27
Endometrial Cancer,24
Acute Myeloid Leukemia,21
Multiple Myeloma,19
Bladder Cancer,18
HER2-positive Breast Cancer,17
Gastric Cancer,16
Hodgkin Lymphoma,16
Urothelial Cancer,16
Fallopian Tube Cancer,16
Prostate Cancer,15
Cervical Cancer,12
Pancreatic Cancer,11
Diffuse Large B-Cell Lymphoma,11
Prognostic Breast Cancer,11
Colorectal Cancer,10
Primary Peritoneal Cancer,10
"Lymphoma, Large B-Cell, Diffuse",9
"Lymphoma, Large-Cell, Anaplastic",9
Hodgkin Disease,9
"Cancer, Non-Small-Cell Lung",9
"Lymphoma, B-Cell",9
Epithelial Ovarian Cancer,9
NSCLC,9
Anatomic Breast Cancer,9
"Lymphoma, Non-Hodgkin",9
Non-Hodgkin Lymphoma,8
Renal Cell Cancer,8
Gastroesophageal Junction AdenoCancer,8
Head and Neck Cancer,7
Acute Lymphoblastic Leukemia,7
Small Cell Lung Cancer,7
Metastatic Solid Cancer,7
"Disease, Hodgkin",7
Invasive Breast Cancer,7
HER2-negative Breast Cancer,7
Peritoneal Cancer,7
Mycosis Fungoides,7
ACUTE LYMPHOBLASTIC LEUKEMIA,7
Ovary Cancer,6
Esophageal Cancer,6
HER2 Positive Breast Cancer,6
Biliary Tract Cancer,6
Melanoma,6
HER2-Positive Solid Cancer,5
Follicular Lymphoma,5
Non Small Cell Lung Cancer,5
Lung Cancer,5
Salivary Gland Cancer,5
Chronic Lymphocytic Leukemia,5
Glioblastoma Multiforme,5
Pancreas Cancer,5
Metastatic Urothelial Cancer,5
Leukemia,5
Head and Neck Squamous Cell Cancer,5
Urinary Bladder Cancer,5
HER2-positive Solid Cancer,5
or Metastatic Solid Cancer,4
B-Cell Lymphoma,4
Diffuse Large B Cell Lymphoma,4
B-cell Lymphoma,4
Hepatocellular Cancer,4
Glioblastoma,4
Metastatic Castration-resistant Prostate Cancer,4
"Solid Cancer, Adult",4
Mesothelioma,4
Acute Myelogenous Leukemia,4
Recurrent Breast Cancer,4
Rectal Cancer,4
Metastatic Cancer,4
Squamous Cell Cancer of the Head and Neck,4
Renal Pelvis Cancer,4
Cervix Cancer,3
Esophagus Cancer,3
Endometrium Cancer,3
Pancreatic AdenoCancer,3
Refractory B Acute Lymphoblastic Leukemia,3
Recurrent B Acute Lymphoblastic Leukemia,3
Recurrent Ovarian Cancer,3
Non-small Cell Lung Cancer (NSCLC),3
T-Cell Lymphoma,3
HER2 Gene Mutation,3
Muscle Invasive Bladder Cancer,3
B-cell Non-Hodgkin Lymphoma,3
"recurrent or metastatic cervical cancer MedDRA version: 21.1 Level: PT Classification code 10008342 Term: Cervix Cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",3
Metastatic Colorectal Cancer,3
Urologic Cancer,3
Non-Hodgkin's Lymphoma,3
Non-Hodgkins Lymphoma,3
Hormone Receptor Positive Breast Cancer,3
Gastric AdenoCancer,3
Precursor B-cell Lymphoblastic Leukemia-Lymphoma,3
B-cell Acute Lymphoblastic Leukemia,3
Brain Metastases,3
B-Cell Non-Hodgkin Lymphoma,3
Precursor b-Cell Lymphoblastic Leukemia-Lymphoma,3
Metastatic Triple-negative Breast Cancer,3
Locally Breast Cancer,3
Diffuse Cutaneous Systemic Sclerosis,3
"Lymphoma, Follicular",3
Ureteral Cancer,3
Solid Malignancies,3
Metastatic Triple-Negative Breast Cancer,3
Triple-Negative Breast Cancer,3
Non-Small Cell Lung Cancer (NSCLC),3
Non-hodgkin's Lymphoma,3
Childhood Hodgkin Lymphoma,3
Triple-negative Breast Cancer,3
Prostate Cancer (CRPC),2
Myeloproliferative Cancer,2
"Leukemia, Myelocytic, Acute",2
Refractory Acute Myeloid Leukemia,2
Recurrent Acute Myeloid Leukemia,2
"Lymphoma, T-Cell, Peripheral",2
"Lymphoma, T-cell",2
Locally or Metastatic Non-Small Cell Lung Cancer,2
Malignant Solid Cancer,2
HER2-positive Metastatic Breast Cancer,2
Undifferentiated Pleomorphic Sarcoma,2
Unresectable/metastatic breast cancer with human epidermal growth factor receptor 2 (HER2)-positive expression MedDRA version: 20.0 Level: LLT Classification code 10027475 Term: Metastatic breast cancer System Organ Class: 100000004864,2
CLASSICAL HODGKIN LYMPHOMA,2
Myelodysplastic Syndrome,2
Prostatic Cancer,2
HER-2 Gene Amplification,2
ER-Negative Breast Cancer,2
"Lymphoma, T-Cell",2
Cancer Metastasis,2
Hodgkin's Lymphoma,2
Gastrointestinal Cancer,2
Esophageal AdenoCancer,2
Gastroesophageal-junction Cancer,2
HER-2 Protein Overexpression,2
Myelodysplastic Syndromes,2
HER2 Low Breast Cancer,2
Stomach Cancer,2
Burkitt Lymphoma,2
HER2 Overexpressing Gastric Cancer,2
"First-line (1L) Triple Negative Breast Cancer (TNBC) - the subtype of breast cancer characterized by a lack of Cancer expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. MedDRA version: 20.0 Level: PT Classification code 10075566 Term: Triple negative breast cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",2
"HER2-positive Metastatic Breast Cancer MedDRA version: 20.0 Level: SOC Classification code 10029104 Term: Cancer benign, malignant and unspecified (incl cysts and polyps) System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",2
Relapsed/Refractory Multiple Myeloma MedDRA version: 21.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864,2
PD-L1 Negative,2
Oncology,2
Hormone-receptor-positive Breast Cancer,2
Recurrent Solid Cancer,2
HER2-positive Early Breast Cancer,2
or Metastatic Breast Cancer,2
"Treatment in locally unresectable metastatic patients with HER2 overexpressed (IHC 3+ or IHC 2+) and HER2 low (1+) selected solid Cancer not eligible for curative therapy. MedDRA version: 20.0 Level: SOC Classification code 10029104 Term: Cancer benign, malignant and unspecified (incl cysts and polyps) System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",2
Hormone Receptor Positive Cancer,2
Early-stage Breast Cancer,2
Large B-cell Lymphoma,2
Medical Oncology,2
Early Breast Cancer,2
Inflammatory Breast Cancer,2
Cutaneous T-cell Lymphoma (CTCL),2
Sezary Syndrome,2
"Lymphoma, Mantle-Cell",2
"Patients with epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer (hereafter collectively referred to as platinum-resistant ovarian cancer and abbreviated as PROC) MedDRA version: 20.0 Level: PT Classification code 10033128 Term: Ovarian cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10016180 Term: Fallopian tube cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.1 Level: PT Classification code 10080244 Term: Peritoneal cancer index System Organ Class: 10022891 - Investigations",2
Anaplastic Large-Cell Lymphoma,2
"Cancer, Transitional Cell",2
Urethral Cancer,2
"Non-Small Cell Lung Cancer MedDRA version: 21.1 Level: PT Classification code 10061873 Term: Non-small cell lung cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",2
Gliosarcoma,2
Leptomeningeal Metastasis,2
ER-negative Breast Cancer,2
Breast Cancer Female,2
HER2-mutated metastatic Non-Small Cell Lung Cancer (NSCLC) MedDRA version: 20.0 Level: LLT Classification code 10025044 Term: Lung cancer System Organ Class: 100000004864,2
Non-Small Cell Squamous Lung Cancer,2
Ovarian Epithelial Cancer,2
Lymphomatoid Papulosis,2
Pancreatic Ductal AdenoCancer,2
Large B-Cell Lymphoma,2
Solid Tumours,2
Refractory Diffuse Large B-Cell Lymphoma,2
Classical Hodgkin Lymphoma,2
"Prostatic Cancer, Castration-Resistant",2
Non-muscle Invasive Bladder Cancer,2
Anaplastic Large-cell Lymphoma,2
HER2-Positive Metastatic Breast Cancer,2
"Cancer, Squamous Cell of Head and Neck",2
Safety,2
Malignant Glioma,2
Non-Muscle Invasive Bladder Cancer,2
Non-Small-Cell Lung Cancer,2
Solid Cancer (Excluding Gastric Cancer and Breast Cancer),1
"Gastric cancer, Gastroesophageal junction cancer",1
Squamous Cell Cancer of the Head and Neck (SCCHN),1
Lung Cancer(NSCLC),1
Enteropathy Associated T-cell Lymphoma,1
Gastroesophageal Junction Cancer,1
Blastic Plasmacytoid Dendritic Cell Cancer,1
SCLC,1
Merkel Cell Cancer,1
Anaplastic Thyroid Cancer,1
Differentiated Thyroid Cancer,1
Recurrent Mixed Phenotype Acute Leukemia,1
Refractory T Acute Lymphoblastic Leukemia,1
Recurrent T Acute Lymphoblastic Leukemia,1
Refractory Mixed Phenotype Acute Leukemia,1
or Metastatic Solid Malignancies,1
HER2-positive Biliary Tract Cancer,1
HER2-Positive Salivary Gland Cancers,1
BRCA2 Gene Mutation,1
BRCA1 Gene Mutation,1
Recurrent Uterine Corpus Cancer,1
Recurrent Fallopian Tube Cancer,1
Recurrent Uterine Serous Cancer,1
Recurrent Uterine Carcinosarcoma,1
Recurrent Primary Peritoneal Cancer,1
Platinum Resistant Ovarian Cancer,1
Folate Receptor Alpha Positive,1
"Ovarian Cancer, Pancreatic Cancer",1
Additional Indications Below for Module 4 and 5,1
Small Cell Lung Cancer Only in Module 5,1
Biliary Cancer,1
Relapsed/Refractory Multiple Myeloma,1
"Inoperable or Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer that Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy MedDRA version: 23.0 Level: PT Classification code 10083232 Term: HER2 negative breast cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
"Lymphoma, NK-cell",1
/ Metastatic Her-2 Positive Breast Cancer,1
Mantle-Cell Lymphoma,1
"Follicular Lymphoma, Grade 3",1
"Diffuse, Large B-Cell, Lymphoma",1
Gastric and pancreatic adenoCancer MedDRA version: 21.1 Level: LLT Classification code 10066354 Term: AdenoCancer of the gastroesophageal junction System Organ Class: 100000004864 MedDRA version: 21.1 Level: LLT Classification code 10051971 Term: Pancreatic adenoCancer System Organ Class: 100000004864,1
B Cells--Cancer,1
Indolent Lymphoma,1
Non Hodgkin Lymphoma,1
Mantle Cell Lymphoma,1
or Metastatic Biliary Tract Cancer,1
HER2 Mutant Non-small Cell Lung Cancer,1
HER2 Amplification,1
Malignant Melanoma,1
Pancreatic Ductal Cancer,1
Castration-Resistant Prostatic Cancer,1
Myxofibrosarcoma,1
"Lymphoma, Non Hodgkin",1
/ Metastatic Solid Cancer,1
Esophageal SCC,1
Hormone Receptor-positive Breast Cancer,1
Tissue Factor-Expressing Solid Cancer,1
SCCHN,1
HER2-mutant Non-Small Cell Lung Cancer,1
PD-L1 Positive,1
Solid Cancer Cancers,1
Urinary Tract Cancers,1
Squamous Cell Cancer,1
Mesothelioma; Pleura,1
Mesotheliomas Pleural,1
"Cancer, Ovarian",1
Recurrent Glioblastoma Multiforme,1
"Her2-positive, unresectable and/or metastatic breast cancer.",1
"Part 2: HER2 Expressing/Amplified Solid Cancer Excluding Breast, Gastric, Colorectal Cancer",1
"Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Cancer, Any Cancer Type Excluding Breast, Gastric, Colorectal Cancer",1
Bile Duct Cancer,1
Colo-rectal Cancer,1
Mucoepidermoid Cancer,1
Liver Cancer,1
Recurrent Renal Cell Cancer,1
Mouth Cancer,1
Recurrent Prostate Cancer,1
Palate Cancer,1
CholangioCancer,1
Tongue Cancer,1
Lip Cancer,1
Mucinous Breast Cancer Recurrent,1
Larynx Cancer,1
HER2 Positive Gastric Cancer,1
Skin Cancer,1
Recurrent Colon Cancer,1
Rare Diseases,1
Recurrent Gastric Cancer,1
Mucinous AdenoCancer Gastric,1
Breast Cancer Malignant Primary,1
Tonsil Cancer,1
"Cancer of the ovary, cervix, endometrium, bladder, prostate (castrationresistant prostate cancer [CRPC]), esophagus, lung (non-small cell lung cancer [NSCLC]), and Squamous cell Cancer of the head and neck (SCCHN) MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: HLT Classification code 10014742 Term: Endometrial Cancer malignant System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10008342 Term: Cervix Cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10023774 Term: Large cell lung cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.1 Level: PT Classification code 10062878 Term: Gastrooesophageal cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10005003 Term: Bladder cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: SOC",1
Upper Tract Urothelial Cancer,1
UTUC,1
"Leukemia, Hairy Cell",1
Locally or Metastatic Breast Cancer,1
Cancer - Any cancer,1
Cholangiocellular Cancer,1
PR-Negative Breast Cancer,1
Metastatic Urothelial Cancer of the Renal Pelvis and Ureter,1
"recurrent or cervical cancer MedDRA version: 21.1 Level: PT Classification code 10008342 Term: Cervix Cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
Synchronous Bilateral Breast Cancer,1
Multifocal Breast Cancer,1
or Metastatic Urothelium Cancer,1
Breast Cancer; HER2-positive; Metastatic,1
Relapsed or Refractory Multiple Myeloma,1
NON-breast HER2+ Malignancies,1
Peripheral T Cell Lymphoma,1
HER2-over-expressing or HER2-mutated unresectable and/or metastatic non-squamous NSCLC,1
Metastatic Castration Resistant Prostate Cancer,1
Renal Pelvis and Ureter Urothelial Cancer,1
NMIBC,1
Locally or Metastatic Solid Cancer,1
HNSCC,1
"Cancer, Gastrointestinal",1
Recurrent Hodgkin Lymphoma,1
Refractory Hodgkin Lymphoma,1
"Leukemia, Myeloid, Acute",1
Left Ventricular Function Systolic Dysfunction,1
"Cancer, Lung",1
Nonsmall Cell Lung Cancer,1
Hematological Malignancies,1
Refractory Non-Hodgkin Lymphoma,1
Aggressive Non-Hodgkin Lymphoma,1
Relapsed Non Hodgkin Lymphoma,1
HER2 Mutations Breast Cancer,1
Recurrent or cervical cancer MedDRA version: 21.1Level: PTClassification code: 10008342Term: Cervix CancerSystem Organ Class: 100000004864,1
MedDRA version: 21.1Level: PTClassification code: 10008342Term: Cervix CancerSystem Organ Class: 100000004864,1
Cancers,1
High Grade Serous AdenoCancer of Ovary,1
Infiltrating Bladder Urothelial Cancer With Squamous Differentiation,1
Unresectable Urothelial Cancer,1
Locally Urothelial Cancer,1
Acute Promyelocytic Leukemia,1
HER2-positive Gastric Cancer or Gastroesophageal Junction AdenoCancer,1
Platinum-resistant Ovarian Cancer,1
HER2 Expressing Breast or Gastric/Stomach Cancers,1
Resectable Non-Small-Cell Lung Cancer,1
or Metastatic Non-Small-Cell Lung Cancer,1
Digestive System Cancer,1
Cancer by Site,1
"Inoperable, locally , recurrent or metastatic non-squamous non-small cell lung cancer MedDRA version: 20.0 Level: PT Classification code 10061873 Term: Non-small cell lung cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
ALL,1
HR-Positive Breast Cancer,1
NSCL2 Gene Mutation,1
GastroEsophageal Cancer,1
ER+ Breast Cancer,1
Cervical Squamous Cell Cancer,1
Colorectal Cancer Metastatic,1
"HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Breast Cancer",1
Lung Cancer (NSCLC),1
"Cancer of the ovary, cervix, endometrium, bladder, prostate (castration-resistant prostate cancer [CRPC]), esophagus or lung (non-small cell lung cancer [NSCLC]) MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: HLT Classification code 10014742 Term: Endometrial Cancer malignant System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10008342 Term: Cervix Cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.1 Level: PT Classification code 10062878 Term: Gastrooesophageal cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10023774 Term: Large cell lung cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10005003 Term: Bladder cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: SOC Classification code 10029104 Term: Cancer benign, malignant and unspecified (incl cysts and polyps) System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10033128 Term: Ovarian cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
Metastatic Squamous Cell Cancer of the Head and Neck,1
Recurrent Squamous Cell Cancer of the Head and Neck,1
Squamous Cell Cancer of Head and Neck,1
Urachal AdenoCancer,1
Unresectable Bladder Cancer,1
Bladder Squamous Cell Cancer,1
Malignant Renal Pelvis Cancer,1
Locally Bladder Cancer,1
Malignant Ureter Cancer,1
Malignant Urethral Cancer,1
Metastatic Bladder Cancer,1
Bladder AdenoCancer,1
Thymic Cancer,1
Thymoma,1
"Leukemia, Acute Lymphoblastic",1
HER-2 Positive Breast Cancer,1
and Metastatic Solid Cancer,1
HER2 Positive Metastatic Breast Cancer,1
Gene Abnormality,1
Gene Product Sequence Variation,1
Locally or Metastatic Urothelial Cancer,1
Light Chain (AL) Amyloidosis,1
Human Epidermal Growth Factor 2 Positive Cancer of Breast,1
Health Condition 1: - Health Condition 2: D758- Other specified diseases of bloodand blood-forming organs Health Condition 3: D758- Other specified diseases of bloodand blood-forming organs,1
Lymphatic Diseases,1
Adult T-Cell Leukemia/Lymphoma,1
Acute Lymphoid Leukemia,1
"Anemia, Refractory, With Excess of Blasts",1
Relapsed B-Cell Non-Hodgkin Lymphoma,1
Refractory B-Cell Non-Hodgkin Lymphoma,1
"Second- or Third-Line Recurrent or Metastatic Cervical Cancer MedDRA version: 21.1 Level: PT Classification code 10008342 Term: Cervix Cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
Solid Cancer Cancer,1
Human Epidermal Growth Factor 2 Low Breast Cancer,1
Relapsed or Refractory Hodgkin Lymphoma,1
Relapsed or Refractory Anaplastic Large-cell Lymphoma,1
Folate Receptor-Alpha Positive,1
Gastroesophageal AdenoCancer,1
Locally or Metastatic Unresectable Urothelial Cancer,1
CD22 Positive,1
Blasts 5 Percent or More of Bone Marrow Nucleated Cells,1
Philadelphia Chromosome Positive,1
HER2-expressing locally or metastatic malignant solid Cancer,1
Castration-resistant Prostate Cancer,1
"High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements",1
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements,1
Double-Expressor Lymphoma,1
High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements,1
Metastatic Malignant Cancer in the Brain,1
Metastatic HER2 Negative Breast Cancer,1
"Leukemia, Lymphoblastic,Acute",1
"Leukemia, Acute Myeloid",1
Unresectable or Metastatic Solid Malignancy,1
Cancer Malignant,1
"Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia",1
B-cell Non Hodgkin Lymphoma,1
Muscle-Invasive Bladder Cancer,1
Localized Muscle Invasive Bladder Urothelial Cancer,1
Esophageal Squamous Cell Cancer,1
Gynecological Malignancy,1
"-III triple-negative breast cancer with residual invasive disease after neoadjuvant therapy. MedDRA version: 20.0 Level: PT Classification code 10075566 Term: Triple negative breast cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
Locally or Unresectable Metastatic Breast Cancer,1
Endometrioid AdenoCancer,1
Hormone Receptor Negative Cancer,1
Triple-Negative Breast Cancer (TNBC),1
Residual Cancer,1
Circulating Cancer DNA,1
Cutaneous Lymphoma,1
Non-Hodgkin Lymphoma (NHL),1
dcSSc,1
Scleroderma,1
High Grade Epithelial Ovarian Cancer,1
Hormone Receptor-positive/Her2 Negative Breast Cancer,1
Breast AdenoCancer,1
"Leukemia, Myeloid",1
Metastatic gpNMB Over-expressing Triple Negative Breast Cancer,1
HER2 Expressing or Mutated Malignant Solid Cancer,1
Hairy Cell Leukemia,1
Refractory or Recurrent CD30+ Hematologic Malignancies,1
HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy,1
Metastatic Gastric AdenoCancer,1
"Lung Cancer, Nonsmall Cell",1
Acute Myeloid Leukaemia,1
Leukaemia Cancer Leukaemia,1
HER2-positive,1
"Melanoma,",1
Richter Syndrome,1
Recurrent Small Cell Lung Cancer,1
"Unresectable or metastatic gastric or gastro-esophageal junction (GEJ) adenoCancer that has progressed on or after a trastuzumab-containing regimen MedDRA version: 21.1 Level: LLT Classification code 10071114 Term: Metastatic gastric adenoCancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 21.1 Level: LLT Classification code 10066354 Term: AdenoCancer of the gastroesophageal junction System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
Disease: Lymphoma (Hodgkin's) Cancer Hodgkin lymphoma,1
Topic: National Cancer Research Network,1
Subtopic: Lymphoma,1
"Lymphoma, T-Cell, Cutaneous",1
HR+/HER2- Metastatic Breast Cancer,1
Digestive Cancer,1
Uterine Cervical Cancer,1
HER2-expressing,1
Cutaneous T Cell Lymphoma,1
Small-Cell Lung Cancer,1
Non-Hodgkin's Disease,1
Esophagogastric AdenoCancer,1
"C349 Bronchus or lung, unspecified Bronchus or lung, unspecified",1
C349,1
HER2 Negative Breast Cancer,1
ER Positive Breast Cancer,1
Peripheral T-cell Lymphoma,1
Non-Small Cell Non-Squamous Lung Cancer,1
Mixed Phenotype Acute Leukemia,1
Myelodysplastic/Myeloproliferative Cancer,1
AdenoCancer Gastric With Metastases,1
AdenoCancer - GEJ,1
Hormone-refractory Prostate Cancer,1
Head and Neck Cancers- Squamous Cell,1
Cancer Breast,1
Gastrointestinal Malignancies,1
Wet Age-related Macular Degeneration,1
Ovarian Endometrioid AdenoCancer,1
Lung AdenoCancer,1
Endometrial Serous AdenoCancer,1
Endometrial Endometrioid AdenoCancer,1
Ovarian Clear Cell Cancer,1
Malignant Pleural Mesothelioma,1
Endometrial AdenoCancer,1
Endometrial Clear Cell AdenoCancer,1
Ovarian Mucinous AdenoCancer,1
Ovarian Clear Cell AdenoCancer,1
Recurrent B Lymphoblastic Lymphoma,1
Refractory B Lymphoblastic Lymphoma,1
High-risk Myelodysplastic Syndrome,1
DLBCL,1
Liver Failure,1
HER2-positive Colorectal Cancer,1
HER2-positive Gastroesophageal Cancer,1
HER2-positive Endometrial Cancer,1
Urothelial Bladder Cancer,1
Sarcoma,1
Non Small Cell Lung Cancer (NSCLC),1
Thyroid Cancer,1
"Recurrent Epithelial Ovarian, Fallopian or Peritoneal Cancer",1
"Brain Metastases, Adult",1
Grade 3b Follicular Lymphoma,1
Primary Mediastinal (Thymic) Large B-Cell Lymphoma,1
Recurrent Diffuse Large B-Cell Lymphoma,1
Transformed Follic Lymph to Diff Large B-Cell Lymphoma,1
Transformed Marg Zone Lymph to Diff Large B-Cell Lymphoma,1
Cancer of the Breast,1
Cutaneous T-Cell Lymphoma,1
Primary Cutaneous Anaplastic Large Cell Lymphoma,1
Locally /Metastatic Solid Tumours,1
"Cancer of the ovary, cervix, endometrium, bladder, prostate (castration-resistant prostate cancer [CRPC]), head and neck (squamous cell Cancer of the head and neck [SCCHN]), esophagus or lung (non-small cell lung cancer [NSCLC] MedDRA version: 20.0 Level: HLT Classification code 10014742 Term: Endometrial Cancer malignant System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 21.1 Level: PT Classification code 10008342 Term: Cervix Cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.1 Level: PT Classification code 10062878 Term: Gastrooesophageal cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 21.1 Level: PT Classification code 10023774 Term: Large cell lung cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10005003 Term: Bladder cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: SOC Classification code 10029104 Term: Cancer benign, malignant and unspecified (incl cysts and polyps) System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10033128 Term: Ovarian cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 21.1 Level: PT Classification code 10067821 Term: Head and neck cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
Malignant Cancer,1
Her 2 Positive Breast Cancer,1
Breast Cancer Metastatic,1
Unresectable or Melanoma,1
Recurrent Glioblastoma,1
Brain Cancer,1
High-risk Non-muscle Invasive Bladder Cancer,1
Breast Diseases,1
Capecitabine,1
HER2-positive Breast With Liver Metastases,1
Cancer Non-small Cell Lung,1
"Metastatic Pancreatic Ductal AdenoCancer MedDRA version: 20.0 Level: PT Classification code 10073364 Term: Ductal adenoCancer of pancreas System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
"Cancer, Renal Cell",1
Extensive-stage Small-cell Lung Cancer,1
Relapsed / Refractory AML,1
Relapsed / Refractory MDS,1
Unresectable Breast Cancer,1
Metastatic Lung Cancer,1
Relapsed Lymphoid Malignancy,1
Refractory Lymphoid Malignancy,1
Sézary Syndrome,1
GBM,1
Prostate Cancer Metastatic,1
Multiple Myeloma in Relapse,1
Multiple Myeloma With Failed Remission,1
Androgen-Resistant Prostatic Cancer,1
Castration Resistant Prostatic Cancer,1
"Unspecified Adult Solid Cancer, Protocol Specific",1
"Solid Cancer With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast",1
Locally Cancer,1
Clear Cell Renal Cell Cancer,1
Clear Cell Renal Cancer,1
Renal Cell AdenoCancer,1
CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma,1
Hematologic Disorder,1
Cutaneous Lymphomas,1
Skin Lymphoma,1
"Lymphoma, Primary Cutaneous Anaplastic Large Cell",1
Papillary thyroid Cancer,1
HER2 Low Breast AdenoCancer,1
Extensive Stage-small Cell Lung Cancer,1
"various /Metastatic solid tumour types - Endometrial Cancer - Gastric Cancer - Ovarian Cancer - Metastatic castration-resistant prostate cancer - Colorectal cancer MedDRA version: 12.0 Level: HLGT Classification code 10007129 Term: Cancer-related morbidities System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
Graft vs. Host Disease,1
Locally or Early Breast Cancer,1
HER2-Negative Metastatic Breast Cancer,1
"Hodgkin Lymphoma, Adult",1
"Lymphoma, Marginal Zone",1
Recurrent or Metastatic Nasopharyngeal Cancer,1
Refractory Follicular Lymphoma,1
Recurrent Follicular Lymphoma,1
Neoplasia,1
"Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma",1
Clinical Efficacy,1
High Grade Ovarian Cancer,1
"recurrent or metastatic cervical cancer MedDRA version: 20.0 Level: PT Classification code 10008342 Term: Cervix Cancer System Organ Class: 10029104 - Cancer benign, malignant and unspecified (incl cysts and polyps)",1
Mast Cell Leukemia,1
Aggressive Systemic Mastocytosis,1
Systemic Mastocytosis,1
Salivary Gland Cancers,1
Gland,1
Malignant Cancer of Breast,1
HER2,1
Metastatic Prostate Cancer,1
Diffuse Large B-cell-lymphoma,1
Macular Edema,1
Retinal Vein Occlusion,1
Germ Cell Cancer,1
Exocrine Pancreatic Cancer,1
Relapsed Diffuse Large B-cell Lymphoma,1
"Gastric Cancer, AdenoCancer",1
Richter's Transformation,1
Refractory Multiple Myeloma,1
Relapsed Cancer,1
NK/T Cell Lymphoma Nos,1
Pharmacokinetics,1
ECG,1
Chemotherapy-induced Alopecia,1
Gastric or Gastroesophageal Junction (GEJ) AdenoCancer,1
Anaplastic Astrocytomas,1
High-grade B-cell Lymphoma,1
"Cancer, Breast",1
"AdenoCancer, Gastric",1
Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance,1
Acute Lymphocytic Leukemia,1
"Infusions, Intravenous",1
Metastatic Castration Resistant Prostate Cancer (mCRPC),1
HER2-Positive Primary Breast Cancer,1
Residual Invasive Breast Cancer,1
Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
Grade 3a Follicular Lymphoma,1
Indolent B-Cell Non-Hodgkin Lymphoma,1
Grade 1 Follicular Lymphoma,1
Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
Marginal Zone Lymphoma,1
Grade 2 Follicular Lymphoma,1
Gastrooesophageal Cancer,1